![Yong Ben](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yong Ben
Director/Board Member at
CORBUS PHARMACEUTICALS HOLDINGS, INC.
Net worth: 410 798 $ as of 29/06/2026
Profile
Currently, Yong Ben holds the position of Chief Medical Officer-Immuno & Oncology Department at BeiGene Ltd. Dr. Ben received a doctorate from Norman Bethune Medical University and an MBA from the University of California San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.06% | 30/06/2026 | 44,576 ( 0.06% ) | 339 669 $ | 29/06/2026 |
| 18/05/2026 | 7,583 ( 0.04% ) | 71 129 $ | 29/06/2026 |
Yong Ben active positions
| Companies | Position | Start |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 28/02/2023 |
Eight Roads Capital Advisors (CHINA)
 Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 31/07/2022 |
Former positions of Yong Ben
| Companies | Position | End |
|---|---|---|
| BEIGENE LTD | Chief Tech/Sci/R&D Officer | - |
| BIOATLA, INC. | Corporate Officer/Principal | 31/01/2019 |
Training of Yong Ben
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norman Bethune Medical University
 Norman Bethune Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAtla, Inc.
 BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Finance |
- Stock Market
- Insiders
- Yong Ben
